Kinnate Biopharma Inc. KNTE
Trading inactive
| Name of reporting person | Citizenship or organization | Sole voting power | Shared voting power | Sole dispositive power | Shared dispositive power | Amount beneficially owned | Percent of class | Accepted date |
|---|---|---|---|---|---|---|---|---|
| (1) BlackRock, Inc. | Delaware | 2281534 | 0 | 2335818 | 0 | 2335818 | 5.3 % | 03/02/2023 |
| Weston Nichols | Delaware | 0 | 2213178 | 0 | 0 | 2213178 | 5 % | 23/01/2023 |
| Lynx1 Capital Management LP | Delaware | 0 | 2213178 | 0 | 0 | 2213178 | 5 % | 23/01/2023 |
| RA Capital Management, L.P. | Delaware | 0 | 3593052 | 0 | 3593052 | 3593052 | 8.2 % | 14/02/2022 |
| RA Capital Healthcare Fund, L.P. | Delaware | 0 | 2822131 | 0 | 2822131 | 2822131 | 6.5 % | 14/02/2022 |
| Peter Kolchinsky | United States of America | 0 | 3593052 | 0 | 3593052 | 3593052 | 8.2 % | 14/02/2022 |
| Rajeev Shah | United States of America | 0 | 3593052 | 0 | 3593052 | 3593052 | 8.2 % | 14/02/2022 |
| Vida Ventures, LLC | 0 | 2747433 | 0 | 2747433 | 2747433 | 6.3 % | 10/02/2022 | |
| VV Manager, LLC | 0 | 2747433 | 0 | 2747433 | 2747433 | 6.3 % | 10/02/2022 | |
| Rajeev Shah | Delaware | 0 | 3593052 | 0 | 3593052 | 3593052 | 8.3 % | 16/02/2021 |
| 2 | Delaware | 0 | 2551243 | 0 | 2551243 | 10 | 5.9 % | 16/02/2021 |
| 2 | Delaware | 0 | 3593052 | 0 | 3593052 | 3593052 | 8.3 % | 16/02/2021 |
| 2 | Delaware | 0 | 3593052 | 0 | 3593052 | 3593052 | 8.3 % | 16/02/2021 |
| Thomas Lips | Switzerland | 0 | 3008243 | 0 | 3008243 | 3008243 | 6.9 % | 16/02/2021 |
| Nextech V GP S.à r.l. | Luxembourg | 3008243 | 0 | 3008243 | 0 | 3008243 | 6.9 % | 16/02/2021 |
| Dalia Bleyer | Lithuania | 0 | 3008243 | 0 | 3008243 | 3008243 | 6.9 % | 16/02/2021 |
| Nextech V Oncology S.C.S., SICAV-SIF | Luxembourg | 3008243 | 0 | 3008243 | 0 | 3008243 | 6.9 % | 16/02/2021 |
| Vida Ventures, LLC | 0 | 2747074 | 0 | 2747074 | 2747074 | 6.3 % | 12/02/2021 | |
| VV Manager, LLC | 0 | 2747074 | 0 | 2747074 | 2747074 | 6.3 % | 12/02/2021 | |
| James B. Tananbaum (“Tananbaum”) | U.S. Citizen | 10838311 | 0 | 10838311 | 10 | 10838311 | 25 % | 14/12/2020 |
| Foresite Capital Management V, LLC (“FCM V”) | Delaware | 875001 | 0 | 875001 | 10 | 875001 | 2 % | 14/12/2020 |
| Foresite Capital Opportunity Management V, LLC (“FCOM V”) | Delaware | 291667 | 0 | 291667 | 10 | 291667 | 0.7 % | 14/12/2020 |
| Foresite Capital Opportunity Fund V, L.P. (“FCOF V”) | Delaware | 291667 | 0 | 291667 | 10 | 291667 | 0.7 % | 14/12/2020 |
| Foresite Capital Fund IV, L.P. (“FCF IV”) | Delaware | 9671643 | 0 | 9671643 | 10 | 9671643 | 22.3 % | 14/12/2020 |
| Foresite Capital Management IV, LLC (“FCM IV”) | Delaware | 9671643 | 0 | 9671643 | 10 | 9671643 | 22.3 % | 14/12/2020 |
| Foresite Capital Fund V, L.P. (“FCF V”) | Delaware | 875001 | 0 | 875001 | 10 | 875001 | 2 % | 14/12/2020 |
| OrbiMed Capital LLC | Cayman Islands | 450000 | 0 | 450000 | 10 | 450000 | 1 % | 11/12/2020 |
| OrbiMed Genesis GP LLC | Delaware | 0 | 84599 | 0 | 10 | 84559 | 0.2 % | 11/12/2020 |
| OrbiMed Advisors LLC | Delaware | 0 | 3397929 | 0 | 10 | 3397929 | 7.8 % | 11/12/2020 |
| OrbiMed Capital GP VII LLC | Delaware | 0 | 3313330 | 0 | 10 | 3313330 | 7.6 % | 11/12/2020 |